Recurrent MRSA skin infections in atopic dermatitis

Peck Y Ong

doi:10.1016/j.jaip.2014.04.007

Recurrent MRSA skin infections in atopic dermatitis

J Allergy Clin Immunol Pract. 2014 Jul-Aug;2(4):396-9. doi: 10.1016/j.jaip.2014.04.007. Epub 2014 May 23.

Author

Peck Y Ong¹

Affiliation

¹ Division of Clinical Immunology and Allergy, Children's Hospital Los Angeles, Calif; Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, Calif. Electronic address: pyong@chla.usc.edu.

PMID: 25017526
DOI: 10.1016/j.jaip.2014.04.007

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is a frequent cause of recurrent skin and soft tissue infections. For patients with atopic dermatitis, recurrent skin infections with MRSA often lead to eczema exacerbation. There currently is no standard practice in the prevention of recurrent MRSA soft tissue infections in the general and the atopic dermatitis populations. The current article reviews recent data on S aureus decolonization treatments for the prevention of recurrent MRSA soft tissue infections in the community setting.

Keywords: Bleach; Chlorhexidine; Clorox; Community-associated MRSA; Decolonization; Eczema; Hibiclens; Household contact; Hypochlorite; Skin and soft tissue infection; USA300.

Publication types

Review

MeSH terms

Animals
Anti-Bacterial Agents / therapeutic use*
Dermatitis, Atopic / epidemiology
Dermatitis, Atopic / therapy*
Hexachlorophene / therapeutic use
Humans
Hygiene
Methicillin-Resistant Staphylococcus aureus / physiology*
Mupirocin / therapeutic use
Recurrence
Residence Characteristics
Skin / drug effects
Skin / microbiology
Staphylococcal Infections / epidemiology
Staphylococcal Infections / therapy*

Substances

Anti-Bacterial Agents
Mupirocin
Hexachlorophene